Literature DB >> 15126166

Panophthalmitis due to clostridium septicum.

Daniel C Schickner1, Alon Yarkoni, Paul Langer, Larry Frohman, Xue Chen, Robert Folberg, Lucian V Del Priore.   

Abstract

PURPOSE: To describe patient survival in a rare case of endogenous Clostridium septicum sepsis with panophthalmitis.
DESIGN: Observational case report.
METHODS: Both eyes of a female patient were examined in a hospital setting.
RESULTS: A 68-year-old woman had right orbital pain, proptosis, panophthalmitis, mental confusion and fever for 2 days. Blood cultures were significant for Clostridium septicum. The patient did not improve after treatment with intravenous broad-spectrum antibiotics and the right eye was enucleated. The patient survived the acute infection and extensive systemic evaluation revealed an undiagnosed colon carcinoma that may have been responsible for colonization and vascular dissemination of Clostridium septicum.
CONCLUSIONS: Clostridium septicum panophthalmitis and sepsis can be the presenting sign in patients with unsuspected malignancies, particularly colon cancer. Patients can survive the infection with aggressive therapy with systemic antibiotics combined with removal of the infected tissue.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15126166     DOI: 10.1016/j.ajo.2003.10.030

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  3 in total

1.  A rare case of devastating Clostridium septicum endogenous endophthalmitis.

Authors:  Lorena Karla Rudež; Igor Petrović; Krešimir Bulić; Jelena Juri Mandić
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-11-01       Impact factor: 3.117

2.  Clostridium septicum sepsis and its implications.

Authors:  Muhammad Khalid; Rajeka Lazarus; Ian C J W Bowler; Chris Darby
Journal:  BMJ Case Rep       Date:  2012-09-07

3.  Clostridium septicum gas gangrene in the orbit: a case report.

Authors:  I Fejes; R Dégi; M Végh
Journal:  Infection       Date:  2012-12-01       Impact factor: 3.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.